Phase 4 N=57 Postoperative Pain Control Following Vitreoretinal Surgery
Retinal Detachment · Proliferative Vitreoretinopathy · Retinoschisis
Primary: Mean Pain Score — 2.9; 3.8 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=84 Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease
Pilonidal Sinus · Sinus; Dermal, Pilonidal · Umbilical Granuloma
Primary: Cure Rate — 28; 40 participants
N/A N=11 Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT
Depression
Primary: Hamilton Depression Rating Scale Score — 28.5; 23.0; 20.5; 19.0 units on a scale
Phase 2 N=290 A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Percentage of Participants Who Achieved Disease Activity Score of 28 Joints Using C-Reactive Protein (DAS28 [CRP]) Response at Day 85 — 32.6; 37.5; 63.3; 47.9 percentage…
N/A N=12 Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury
Acute Respiratory Distress Syndrome · Acute Lung Injury
Primary: Oxygenation — 10 Participants
N/A N=15 Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Hyperglycemia · Cardiovascular Disease
Primary: Area Under the Curve of Blood Glucose — 998; 981 mmol/L * min
Phase 3 N=1,047 Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Lung Cancer
Primary: Overall Survival in Lymph Nodes Examined Patients — NA; NA years — p=0.007
Phase 2 N=46 Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Carcinoma of Unknown Primary Origin
Primary: Percentage of Participants With Confirmed Tumor Responses — 36 percentage of participants
Phase 2 N=78 Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Diffuse Large Cell B-lymphoma
Primary: Percentage of Patients With an Overall Response to Study Drug — 24.3; 12.5 percentage of participants
Phase 2 N=80 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
Charcot-Marie-Tooth Disease · Hereditary Neuropathy With Liability to Pressure Palsies · Genetic Disorders
Primary: Safety and Tolerability of PXT3003 — 21; 21; 19; 19 Participants
N/A N=40 CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation
Parkinson's Disease
Primary: Therapeutic Window — 3.81; 2.32 mA
N/A N=115 Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?
Chronic Abdominal Pain · Small Intestinal Bacterial Overgrowth
Primary: The Number of Participants at Baseline With SIBO — 14; 44; 24 Participants
Phase 2 N=69 Combined Treatment for Generalized Anxiety Disorder (GAD)
Generalized Anxiety Disorder
Primary: Hamilton Anxiety Rating Scale (HAM-A) — 25.9; 23.8; 20.9; 19.4 units on a scale — p=.17
N/A N=207 TiLoop® Bra for Breast Reconstruction
Patient and Surgical Related Risk Factors for Complications
Primary: Participants Who Received TiLOOP Mesh Reconstruction — 207 Patients with TiLOOP mesh reconstruction
Phase 3 N=249 3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection
Hepatitis C
Primary: Percentage of Participants Maintaining SVR at the Last Available Visit — 100 Percentage of participants